公开(公告)号：US20240216366A1

公开(公告)日：2024-07-04

申请号：US18435817

申请日：2024-02-07

申请人： ACTELION PHARMACEUTICALS LTD

发明人： Katie AMSSOMS ,  Eddy DE PROOST ,  Wenyu DONG ,  Paul HARTMAN KOK ,  Rene HOLM ,  Kristof KIMPE ,  Greet MEURS ,  Maxim VERSTRAETEN

IPC分类号： A61K31/497 ,  A61K9/19 ,  A61K47/10 ,  A61K47/26

CPC分类号： A61K31/497 ,  A61K9/19 ,  A61K47/10 ,  A61K47/26

摘要： The present invention relates to a pharmaceutical composition comprising the calcium; {4-[(5,6-diphenylpyrazin-2-yl)(propan-2-yl)amino]butoxy}acetate, in particular to long-acting injectables comprising the same, the use of the pharmaceutical composition for the treatment or prevention of specific diseases, and a process to produce it.

公开(公告)号：US20240091223A1

公开(公告)日：2024-03-21

申请号：US18261923

申请日：2022-01-28

申请人： ACTELION PHARMACEUTICALS LTD

发明人： Katie AMSSOMS ,  Eddy DE PROOST ,  Wenyu DONG ,  Paul HARTMAN KOK ,  Rene HOLM ,  Kristof KIMPE ,  Greet MEURS ,  Maxim VERSTRAETEN

IPC分类号： A61K31/497 ,  A61K9/19 ,  A61K47/10 ,  A61K47/26

CPC分类号： A61K31/497 ,  A61K9/19 ,  A61K47/10 ,  A61K47/26

摘要： The present invention relates to a pharmaceutical composition comprising the calcium; {4-[(5,6-diphenylpyrazin-2-yl) (propan-2-yl)amino]butoxy}acetate, in particular to long-acting injectables comprising the same, the use of the pharmaceutical composition for the treatment or prevention of specific diseases, and a process to produce it.